ArticleDigestive diseases and sciences2025

Annual Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease During Infliximab Maintenance Therapy: Balancing Efficacy with Risk of Pharmacokinetic Failure.

Yujin Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.